CClinicalTrials.gg
CompletedNCT03306355PHY1706Updated Jul 27, 2023

Comparison of Clinical Outcomes on Trifocal IOLs FineVision POD F GF and FineVision POD F in Asian Eyes

An interventional study of IOL implantation experimental and IOL implantation active comparator in Cataract, Lens Opacities and Presbyopia, sponsored by Beaver-Visitec International, Inc.. Completed at 1 site in Philippines. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-27.

Sponsored by Beaver-Visitec International, Inc. · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

Prospective, randomised, controlled, single-surgeon, single-center clinical study to compare the clinical outcomes of two trifocal IOLs with different material (hydrophobic and hydrophilic) from the same manufacturer. Implantation of the IOLs is bilaterally.

Read the detailed description

This is a prospective, randomised, controlled, single-surgeon, single-center clinical study whereby patients undergoing routine cataract surgery will have bilateral implantation of trifocal intraocular lenses. The patients will either be implanted with the hydrophobic IOL FineVision POD F GF or the hydrophilic IOL FineVision POD F (both lenses: (PhysIOL, Liège, Belgium).

The devices under investigation (FineVision POD F GF and POD F) are trifocal glistening-free acrylic intraocular lenses (IOLs) manufactured by the sponsor of this study PhysIOL sa/nv. The main difference between the lenses is the material (hydrophobic and hydrophilic). The IOLs will be implanted as part of the routine cataract surgery on patients suffering from cataract development.

Subjects participating in the trial will attend a total of 12 study visits (1 preoperative, 2 operative and 9 postoperative) over a period of 36 months. Subjects would have the option for unscheduled visits if required medically.

Primary endpoint data will be collected at the 3 months follow up visit and secondary endpoint data will be collected at the 3, 12, 24 and 36 months follow up visits. Data analyses will be done after the last patient finished the final examination to support the study publication plan.

02

Conditions studied

  • Cataract
  • Lens Opacities
  • Presbyopia

Keywords

  • Intraocular Lens
  • trifocal
  • hydrophobic
  • hydrophilic
03

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Cataractous eyes with no comorbidity
  • Spontaneously emitting the desire for spectacle independence after surgery and with realistic expectation.
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Unrealistic expectation
  • Age of patient \<45 years
  • Irregular astigmatism
  • Regular corneal astigmatism >0.75 dioptres by an automatic keratometer or biometer or >1.0 dioptres if the steep axis of cylinder is between 90° and 120°
  • Difficulty for cooperation (distance from their home, general health condition)
  • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc...)
  • Any ocular comorbidity
  • History of ocular trauma or prior ocular surgery including refractive procedures
  • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
  • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
  • Age-related Macular Degeneration (AMD) suspicious eyes (determined by OCT)
  • Complicated surgery
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    IOL implantation experimental

    hydrophobic, trifocal intraocular lens POD F GF

    Device: IOL implantation experimental

  • Active comparator
    IOL implantation active comparator

    hydrophilic, trifocal intraocular lens POD F

    Device: IOL implantation active comparator

Interventions

  • DeviceIOL implantation experimental

    Implantation of trifocal IOL POD F GF consisting of hydrophobic material

  • DeviceIOL implantation active comparator

    Implantation of trifocal IOL POD F consisting of hydrophilic material

05

What researchers measure

Primary outcomes

  1. Monocular Uncorrected Distance Visual Acuity (UDVA) under photopic light conditions.

    No statistically significant difference between the two study groups on monocular UDVA at 3 months follow up visit. A significance level of 0.05 or lower (p \< 0.05) will be considered statistically significant. UDVA is measured with ETDRS charts placed in 4m distance according to ISO 11979-7:2014

    Time frame: 3 months postoperative

Secondary outcomes

  1. Manifested refraction

    The manifested refraction is measured by means of a phoropter. The data contains values for sphere, cylinder and axis of cylinder according to ISO 11979-7:2014. This data will also be used to calculate the manifested refractive spherical equivalent (MRSE)

    Time frame: Pre-OP, 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  2. Uncorrected Distance Visual Acuity (UDVA) - monocular

    UDVA is measured with ETDRS charts placed in 4m distance according to ISO 11979-7:2014. This assessment is done monocularly.

    Time frame: 1 day postoperative, 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  3. Uncorrected Distance Visual Acuity (UDVA) - binocular

    UDVA is measured with ETDRS charts placed in 4m distance according to ISO 11979-7:2014. This assessment is done binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  4. Corrected Distance Visual Acuity (CDVA) - monocular

    CDVA is measured with ETDRS charts placed in 4m distance with best aided corrective glasses according to ISO 11979-7:2014. This assessment is done monocularly.

    Time frame: Pre-OP, 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  5. Corrected Distance Visual Acuity (CDVA) - binocular

    CDVA is measured with ETDRS charts placed in 4m distance with best aided corrective glasses according to ISO 11979-7:2014. This assessment is done binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  6. Distance Corrected Intermediate Visual Acuity at 70cm (DCIVA) - monocular

    DCIVA is measured with ETDRS charts placed in 70cm distance with corrective glasses for far distance according to ISO 11979-7:2014. This assessment is done monocularly.

    Time frame: 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  7. Distance Corrected Intermediate Visual Acuity at 70cm (DCIVA) - binocular

    DCIVA is measured with ETDRS charts placed in 70cm distance with corrective glasses for far distance according to ISO 11979-7:2014. This assessment is done binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  8. Uncorrected Intermediate Visual Acuity at 70cm (UIVA) - monocular

    UIVA is measured with ETDRS charts placed in 70cm distance. The examination is done without corrective glasses and according to ISO 11979-7:2014. This assessment is done monocularly.

    Time frame: 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  9. Uncorrected Intermediate Visual Acuity at 70cm (UIVA) - binocular

    UIVA is measured with ETDRS charts placed in 70cm distance. The examination is done without corrective glasses and according to ISO 11979-7:2014. This assessment is done binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  10. Distance Corrected Near Visual Acuity at 35cm (DCNVA) - monocular

    DCNVA is measured with ETDRS charts placed in 35cm distance with corrective glasses for far distance according to ISO 11979-7:2014. This assessment is done monocularly.

    Time frame: 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  11. Distance Corrected Near Visual Acuity at 35cm (DCNVA) - binocular

    DCNVA is measured with ETDRS charts placed in 35cm distance with corrective glasses for far distance according to ISO 11979-7:2014. This assessment is done binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  12. Uncorrected Near Visual Acuity at 35cm (UNVA)

    UNVA is measured with ETDRS charts placed in 35cm distance. The examination is done without corrective glasses and according to ISO 11979-7:2014. This assessment is done monocularly.

    Time frame: 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  13. Uncorrected Near Visual Acuity at 35cm (UNVA)

    UNVA is measured with ETDRS charts placed in 35cm distance. The examination is done without corrective glasses and according to ISO 11979-7:2014. This assessment is done binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  14. Contrast Sensitivity

    Contrast Sensitivity under photopic and mesopic light conditions

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  15. Aberrometry

    Aberrometry outcomes are measured with a standard aberrometer. The following values will be evaluated in this study: Spherical aberrations, high order aberrations, lens tilt.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  16. AcuTarget diagnostic device

    Measurement of Ocular Scatter Index (OSI) score to evaluate and compare the scattering of the implanted lenses.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  17. Visual Functioning Questionnaire - 25 (VFQ-25)

    Outcomes measures of a questionnaire to address the general patient satisfaction and possible side effects of the treatment. For this study, the validated and verified Visual Functioning Questionnaire - 25 (VFQ-25) will be used. The maximum score for each questionaire is 100.

    Time frame: 3 months postoperative, 12 months postoperative.

  18. Defocus Curve

    To assess the visual acuity for different distances, defocus curves under photopic light conditions are measured. This test is performed with best distance corrected refraction and spherical additions ranging from -5.0 D to +1.5 D. This examination is performed monocularly and binocularly.

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  19. Slitlamp examination - Corneal Status

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Corneal Status

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  20. Slitlamp examination - Fundus

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Fundus

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  21. Slitlamp examination - Signs of inflammation

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Signs of inflammation

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  22. Slitlamp examination - Pupillary block

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Pupillary block

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  23. Slitlamp examination - Retinal detachment

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Retinal detachment

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  24. Slitlamp examination - Status of anterior and posterior capsule

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Status of anterior and posterior capsule

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  25. Slitlamp examination - IOL decentration

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL decentration

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  26. Slitlamp examination - IOL tilt

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL tilt

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  27. Slitlamp examination - IOL discoloration

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL discoloration

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  28. Slitlamp examination - IOL opacity

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL opacity

    Time frame: 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

Other outcomes

  1. Intraocular pressure (IOP) measurement

    The IOP will be measured with non-contact tonometer as part of the routine follow up examinations

    Time frame: Pre-OP, 1 day postoperative, 1 week postoperative, 1 month postoperative, 3 months postoperative, 12 months postoperative, 24 months postoperative, 36 months postoperative.

  2. Keratometry

    Keratometric measurements are performed to calculate the required IOL power

    Time frame: Pre-OP

  3. Biometry

    Biometry measurements are performed to calculate the required IOL power

    Time frame: Pre-OP

06

Study locations

1 site
  • Asian Eye Institute
    Makati City, 1200, Philippines
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03306355
Lead sponsor
Beaver-Visitec International, Inc.
Responsible party
Sponsor
First posted
Oct 11, 2017
Start date
Dec 4, 2017
Primary completion
Jan 24, 2019
Completion
Feb 10, 2022
Last update
Jul 27, 2023

Study contacts

Robert Edward Ang, MD
principal investigator · Asian Eye Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion